Skip to content

Enhanced Safety Laser Hair Removal System

Peterio™ - an Add-on Device for Enhanced Safety of Aesthetic Laser Treatments.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00441948
Enrollment
10
Registered
2007-03-01
Start date
2007-05-31
Completion date
2008-04-30
Last updated
2007-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hirsutism, Hypertrichosis

Keywords

Hirsutism, Hypertrichosis

Brief summary

The purpose of this study is to determine whether a new laser system provides better safety and efficacy in hair removal than existing lasers.

Detailed description

Lasers are a well-established, popular modality for removal of unwanted hair. The existing lasers are based on a wavelength that is specifically absorbed by the pigment melanin found in the hair follicle, where the energy is converted to heat resulting in a thermal injury. However, lasers for hair removal are not without limitations. A laser based long-term hair removal treatment is based on thermal destruction of the hair shaft and follicle using wavelengths that are specifically absorbed by the pigment melanin found in the hair follicle. The heating of hair follicle is done through heat dissipation from the hair shaft. One of the significant limitations of this approach is the fact that the epidermis through which the light energy must penetrate is rich in melanin and therefore absorbs a major portion of the energy, resulting in inadequate heating of the hair follicles. The purpose of the study is an evaluation safety and efficacy of a new laser based device.

Interventions

DEVICEPeterio

Sponsors

Scilex Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 18 and 75 years old * Fitzpatrick skin types I to VI

Exclusion criteria

* Age below 18 or above 75 year old * Use of photosensitive medications * Photosensitive diseases * Active infection of any type and active infection or or a history of Herpes Simplex in the treated site * Exposure to sun or artificial tanning during the last 3-4 weeks

Design outcomes

Primary

MeasureTime frame
Hair reduction as counted 1-3 months after each treatment session, depending on the treated area.
Long term clearance will be calculated as the ratio between the value of the baseline hair count taken immediately before the first treatment, and the value obtained at the 3-6 month post treatment hair count.

Secondary

MeasureTime frame
Measuring treatment discomfort as graded by the patients.

Countries

Israel

Contacts

Primary ContactLeon Gilad, MD
leong@cc.huji.ac.il972-26235262

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026